A novel low-toxic liposomal adjuvant: different liposome compositions regulate monocyte activation and viability

摘要

Liposomes are nanoparticles consisting of phospholipidbilayer membranes and aqueous compartments. They can effectively incorporate both hydrophobic and hydrophilic molecules, and therefore have been widely applied as a carrier for gene and drug delivery. Moreover, liposomes are considered as a novel vaccine delivery' system, which encapsulate both Antigen (Ag) and immunomodulatory agents, facilitating Ag delivery to specific immune cells in vivo. Till date, liposomal vaccines against various diseases, such as cancer, HIV, Hepatitis B and malaria, have been investigated and found to be safe. However, their immunogenicity remains to be further improved [1].